Inventor
Jiangwei ZHANG
Inventor
CN
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes45%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations45%
C07DHeterocyclic compounds9%
PatentTitleYear
12,257,251Use of FAK inhibitor in preparation of drug for treating tumors having NRAS mutation202512,121,519Use of BI853520 in cancer treatment202412,115,160Combined use of IN10018 and PLD202412,097,200Combination of BI853520 with chemotherapeutic drugs202412,059,421Use of BI853520 in cancer treatment2024Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2024–2025Patents assigned to INXMED NANJING CO LTD (5)· patent assignee history
2024–2025Based in CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INXMED NANJING CO LTD | 5 | 2024–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 5 | 2024–2025 |